All In Biotech

Drug Trial Radar · NCT07252908

A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TQC3721 Inhalation Powder in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Last checked: Nov 20, 2026Latest source record: Jun 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 195 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

195

Actual

Start

Dec 22, 2025

Primary completion

Apr 28, 2026

Study completion May 7, 2026

Sponsor

Sponsor type
Industry
First posted
Nov 28, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy and safety of TQC3721 inhalation powder in patients with moderate to severe Chronic obstructive pulmonary disease (COPD).

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

  • TQC3721 inhalation powderDrug

    TQC3721 inhalation powder is target inhibitor.

  • Placebo for TQC3721 inhalation powderDrug

    Placebo for TQC3721 inhalation powder.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of the maximum value of Forced Expiratory Volume in the first second (FEV1)Time frame: From baseline to four weeks after treatment

Locations

29 sites in 1 country. Site status is shown where the registry gives one.

  • The Second Affiliated Hospital of Chongqing Medical University

    Chongqing, Chognqing, China

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong, China

  • Jiangmen Central Hospital

    Jiangmen, Guangdong, China

  • Guigang People's Hospital

    Guigang, Guangxi, China

  • Zunyi Medical University Affiliated Hospital

    Zunyi, Guizhou, China

  • Puyang Oilfield General Hospital

    Puyang, Henan, China

  • Yichang Central People's Hospital

    Yichang, Hubei, China

  • The People's Hospital of Liuyang

    Changsha, Hunan, China

  • Xiangtan County People's Hospital

    Xiangtan, Hunan, China

  • The Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Inner Mongolia, China

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China

  • Yixing People'S Hospital

    Wuxi, Jiangsu, China

  • Jiujiang First People's Hospital

    Jiujiang, Jiangxi, China

  • Jiangxi Provincial People's Hospital

    Nanchang, Jiangxi, China

  • Siping Central People's Hospital

    Siping, Jilin, China

  • Heze Municipal Hospital

    Heze, Shandong, China

  • Shanghai JiaoTong University of medicine Ruijin Hospital

    Shanghai, Shanghai Municipality, China

  • Shanghai Pulmonary Hospital

    Shanghai, Shanghai Municipality, China

  • Linfen People's Hospital

    Linfen, Shanxi, China

  • Nuclear Industry 416 Hospital

    Chengdou, Sichuan, China

  • Chengdu Fifth People's Hospital

    Chengdu, Sichuan, China

  • Affiliated Hospital Of ChengDu University

    Chengdu, Sichuan, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China

  • Suining Central Hospital

    Suining, Sichuan, China

  • Yibin Second People's Hospital

    Yibin, Sichuan, China

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China

  • The Fourth Central Hospital of Tianjin

    Tianjin, Tianjin Municipality, China

  • Taizhou central hospital (Taizhou university hospital)

    Taizhou, Zhejiang, China

  • The 2th School of Medicine ,WMU/The 2th affiliated Hospital and Yuying Children's Hospital of WMU

    Wenzhu, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.